EURONEXT:ALTER

Theradiag SA

Stock

EUR

Last Close

1.32

15/12 16:08

Market Cap

17.29M

Beta: −0.26

Volume Today

31.61K

Avg: 3K

PE Ratio

−33.61

PFCF: −10.36

Overview Analysis Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Excel Tearsheet

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22
net income	-1.91M -	-2.96M 54.82%	-2.97M 0.05%	-2.08M 29.74%	-5.96M 186.01%	-785.67K 86.81%	348.91K 144.41%	-231.05K 166.22%	-766.96K 231.94%	-487.58K 36.43%
depreciation and amortization	163.59K -	404.62K 147.35%	550.22K 35.98%	629.60K 14.43%	2.60M 313.70%	626.76K 75.94%
deferred income tax
stock based compensation
change in working capital	-1.59M -	3.29K 100.21%	-134.40K 4,182.59%	-367.09K 173.14%	1.09M 397.88%	-771.39K 170.54%
accounts receivables
inventory
accounts payables
other working capital
other non cash items	46.87K -	45.67K 2.56%	-475.58K 1,141.37%	-622.61K 30.92%	16.50K 102.65%	-617.19K 3,840.34%	-348.91K 43.47%	231.05K 166.22%	766.96K 231.94%	487.58K 36.43%
net cash provided by operating activities	-3.30M -	-2.51M 23.83%	-3.03M 20.51%	-2.44M 19.23%	-2.24M 8.17%	-1.55M 31.04%
investments in property plant and equipment	-580.07K -	-1.01M 74.87%	-546.60K 46.11%	-275.67K 49.57%	-351.13K 27.38%	-121.12K 65.50%
acquisitions net	26.60K -					121.12K -
purchases of investments	-280.61K -	-89.89K 67.96%				-1.74K -
sales maturities of investments	8.60K -			51.63K -	36.76K 28.81%	36.77K 0.04%
other investing activites	26.96K -	144.02K 434.23%	286.60K 99.00%	57.24K 80.03%	201.07K 251.25%	-121.12K 160.24%
net cash used for investing activites	-825.13K -	-960.22K 16.37%	-260.00K 72.92%	-166.79K 35.85%	-113.31K 32.07%	-86.09K 24.02%
debt repayment	-2.21M -	-22.04K 99.00%	-168.19K 663.00%	-48.73K 71.02%	-50.09K 2.78%	-51.49K 2.78%
common stock issued	1.84M -	2.74M 49.28%	3.63M 32.47%	2.47M 31.97%	3.83M 55.06%	6.27K 99.84%
common stock repurchased		-117.07K -
dividends paid		-178.18K -
other financing activites	76.99K -	310.99K 303.91%	72.84K 76.58%	399.24K 448.10%	-7.75K 101.94%	-57.16K 637.49%
net cash used provided by financing activities	-291.73K -	2.74M 1,037.68%	3.54M 29.29%	2.82M 20.23%	3.77M 33.75%	-102.38K 102.71%
effect of forex changes on cash			-1 -	1 200%	1 0%
net change in cash	-4.41M -	-734.88K 83.34%	251.59K 134.24%	211.05K 16.11%	1.42M 571.01%	-1.74M 222.58%
cash at beginning of period	8.41M -	4.01M 52.28%	3.28M 18.30%	3.53M 7.67%	3.74M 5.98%	5.15M 37.74%	3.42M 33.68%
cash at end of period	4.00M -	3.28M 18.02%	3.53M 7.67%	3.74M 5.98%	5.16M 37.84%	3.42M 33.73%	3.42M 0%
operating cash flow	-3.30M -	-2.51M 23.83%	-3.03M 20.51%	-2.44M 19.23%	-2.24M 8.17%	-1.55M 31.04%
capital expenditure	-580.07K -	-1.01M 74.87%	-546.60K 46.11%	-275.67K 49.57%	-351.13K 27.38%	-121.12K 65.50%
free cash flow	-3.88M -	-3.52M 9.06%	-3.57M 1.34%	-2.72M 23.87%	-2.60M 4.56%	-1.67M 35.70%

All numbers in EUR (except ratios and percentages)